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1. Introduction
Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation (or neuromodu-
lation) method. The principle of TMS is based on the Faraday’s principle of electromagnetic 
induction. Around the primary coil, through which a time-varying current is flowing, a 
changing magnetic field is created, which is able to induce a secondary current in conduc-
tors (including human brain) within its reach. It was not until 1985 when Barker and his 
collaborators developed a device that could generate a magnetic field of sufficient intensity 
to depolarize cortical neurons. The generated magnetic field lasts approximately 100–300 ms, 
and its intensity usually ranges from 1.0 to 2.5 T. Secondary current induces depolarization 
or hyperpolarization of cortical neurons—only neurons up to 1.5–2.0 cm from the stimulation 
coil can be influenced directly, but deeper parts of the brain can be influenced via transsynap-
tic connections. TMS causes activation of neurons, metabolic, hemodynamic, and behavioral 
changes [1].
TMS pulses can be administered individually—single-pulse TMS, in pairs few milliseconds 
apart—paired-pulse TMS, or repeatedly in a sequence (called usually train) lasting from sec-
onds to minutes—repetitive TMS (rTMS). The first two types are usually used for research 
or diagnostic purposes (e.g., to assess the physiology of the human motor system, including 
cortical excitability), rTMS is used in the treatment because it can modulate cortical excit-
ability and connectivity by inducing long-term potentiation-like or long-term depression-like 
plastic changes outlasting the stimulation period [2, 3].
The main indication of rTMS is the treatment of major depressive disorder. This method 
was approved in this indication by the Food and Drug Administration (FDA) in 2008; the 
approval was obtained in the European Union, too. Meta-analyses confirm the efficacy of 
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high-frequency (usually 5–25 Hz) rTMS of the left dorsolateral prefrontal cortex (DLPFC), 
low-frequency (≤1 Hz) of the right DLPFC, or bilateral stimulation (combination of high-
frequency and low-frequency stimulation) [4, 5]. Other indications of rTMS are more or less 
experimental. They include the treatment of schizophrenia—either auditory hallucinations 
(low-frequency rTMS of the temporoparietal cortex) or negative symptoms (high-frequency 
rTMS of the left DLPFC) [3]. Another promising indication is the treatment of substance 
addiction, especially nicotine addiction by the decrease of craving (high-frequency rTMS of 
the left DLPFC). Tinnitus is another experimental indication with some promising results as 
well as the treatment of the obsessive compulsive disorder (OCD). Some positive results were 
published in the treatment of posttraumatic stress disorder (high-frequency or low-frequency 
rTMS of the DLPFC). TMS seems to be effective also in algesiology—especially in the treat-
ment of neuropathic pain (high-frequency rTMS of the contralateral M1 area) or maybe of 
complex regional pain syndrome type I. The list of possible indications of rTMS includes 
Parkinson’s disease (high-frequency rTMS of the M1 area), epilepsy (low-frequency focal 
stimulation), postictal rehabilitation, cognitive disorders (mild cognitive impairment and 
Alzheimer’s disease), attention deficit hyperactivity disorder (ADHD), borderline personality 
disorder, eating disorders (especially bulimia nervosa), and some others [1, 4].
The advantage of rTMS is its good tolerability and safety. An only absolute contraindica-
tion is a metallic object in close contact with the stimulation coil. Relative contraindications 
include personal history of epilepsy (high-frequency rTMS); various (vascular, traumatic, 
tumoral, infectious, or metabolic) lesion of the brain; administration of drugs that can lower 
seizure threshold (without anticonvulsant medication); sleep deprivation, alcohol addiction; 
implanted brain electrodes; pregnancy (but several case studies and case series of the safe 
administration of rTMS in pregnant women were published), and severe or recent heart dis-
ease [6, 7]. The most serious side effect is the induction of seizure. However, this risk is very 
low. Other side effects include pain at the stimulation site and headaches. They are more 
frequent than seizures but usually mild. As for mental side effects, several cases of shift into 
mania in patients with bipolar disorder were reported, and several times positive symptoms 
of schizophrenia occurred after the stimulation for negative symptoms [1].
This book describes several aspects of TMS in neuropsychiatry. Hopefully, it will help to 
enhance the knowledge of TMS and its role in this developing discipline.
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